AU2001235496A1 - Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents - Google Patents
Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agentsInfo
- Publication number
- AU2001235496A1 AU2001235496A1 AU2001235496A AU3549601A AU2001235496A1 AU 2001235496 A1 AU2001235496 A1 AU 2001235496A1 AU 2001235496 A AU2001235496 A AU 2001235496A AU 3549601 A AU3549601 A AU 3549601A AU 2001235496 A1 AU2001235496 A1 AU 2001235496A1
- Authority
- AU
- Australia
- Prior art keywords
- alkylating agents
- protein transferase
- transferase inhibitor
- farnesyl protein
- inhibitor combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200691 | 2000-02-29 | ||
EP00200691 | 2000-02-29 | ||
PCT/EP2001/002168 WO2001064217A2 (en) | 2000-02-29 | 2001-02-26 | Combinations of a farnesyl protein transferase inhibitor with nitrogen mustard or nitrosourea alkylating agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001235496A1 true AU2001235496A1 (en) | 2001-09-12 |
Family
ID=8171110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001235496A Abandoned AU2001235496A1 (en) | 2000-02-29 | 2001-02-26 | Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents |
Country Status (6)
Country | Link |
---|---|
US (1) | US20030078281A1 (en) |
EP (1) | EP1261348A2 (en) |
JP (1) | JP2003525244A (en) |
AU (1) | AU2001235496A1 (en) |
CA (1) | CA2397446A1 (en) |
WO (1) | WO2001064217A2 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PA8619901A1 (en) | 2003-12-12 | 2005-11-25 | Wyeth Corp | USEFUL KINOLINES IN THE TREATMENT OF CARDIOVASCULAR DISEASES |
EP1744751A4 (en) * | 2004-03-18 | 2010-03-10 | Brigham & Womens Hospital | Methods for the treatment of synucleinopathies |
WO2005089504A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
US20070293539A1 (en) * | 2004-03-18 | 2007-12-20 | Lansbury Peter T | Methods for the treatment of synucleinopathies |
JP2007529555A (en) * | 2004-03-18 | 2007-10-25 | ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド | How to treat synucleinopathy |
US20050272722A1 (en) * | 2004-03-18 | 2005-12-08 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
US20050272068A1 (en) * | 2004-03-18 | 2005-12-08 | The Brigham And Women's Hospital, Inc. | UCH-L1 expression and cancer therapy |
US20060194821A1 (en) * | 2005-02-18 | 2006-08-31 | The Brigham And Women's Hospital, Inc. | Compounds inhibiting the aggregation of superoxide dismutase-1 |
WO2007075923A2 (en) | 2005-12-23 | 2007-07-05 | Link Medicine Corporation | Treatment of synucleinopathies |
US8232402B2 (en) * | 2008-03-12 | 2012-07-31 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
US20100331363A1 (en) * | 2008-11-13 | 2010-12-30 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
MX2011005096A (en) * | 2008-11-13 | 2011-11-18 | Link Medicine Corp | Azaquinolinone derivatives and uses thereof. |
US20110060005A1 (en) * | 2008-11-13 | 2011-03-10 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
ES2628365T3 (en) | 2012-10-16 | 2017-08-02 | Janssen Pharmaceutica N.V. | Phenyl-linked quinolinyl modulators of ROR-GAMA-T |
PL2909192T3 (en) | 2012-10-16 | 2017-09-29 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of ror-gamma-t |
AU2013331493A1 (en) | 2012-10-16 | 2015-04-09 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORyt |
US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
BR112016008258A2 (en) | 2013-10-15 | 2017-10-10 | Janssen Pharmaceutica Nv | quinolinyl ror? t modulators |
US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
AU2014334619A1 (en) | 2013-10-15 | 2016-04-21 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORyt |
US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW349948B (en) * | 1995-10-31 | 1999-01-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 2-quinolone derivatives |
IL123568A (en) * | 1995-12-08 | 2001-08-08 | Janssen Pharmaceutica Nv | Farnesyl protein transferase inhibiting (imidazole-5-yl) methyl-2-quinolinone derivatives, their preparation, pharmaceutical compositions containing them and their preparation, and medicaments comprising them |
TW591030B (en) * | 1997-03-10 | 2004-06-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles |
HUP0001122A3 (en) * | 1997-04-25 | 2002-03-28 | Janssen Pharmaceutica Nv | Farnesyltransferase inhibiting quinazolinones |
PT1041985E (en) * | 1997-12-22 | 2006-07-31 | Schering Corp | COMBINATION OF BENZOCYCLO-HEPTAPIRIDINE COMPOUNDS AND ANTINEOPLASTIC DRUGS TO TREAT PROLIFERATIVE DISEASES |
FR2772764B1 (en) * | 1997-12-23 | 2000-01-14 | Rhone Poulenc Rorer Sa | NOVEL FARNESYLE TRANSFERASE INHIBITORS, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND THEIR USE IN THE PREPARATION OF MEDICAMENTS |
EP1087770A4 (en) * | 1998-06-15 | 2001-11-14 | Merck & Co Inc | Inhibitors of prenyl-protein transferase |
EP1091736A4 (en) * | 1998-07-02 | 2001-10-24 | Merck & Co Inc | Inhibitors of prenyl-protein transferase |
SK286072B6 (en) * | 1998-12-23 | 2008-02-05 | Janssen Pharmaceutica N. V. | 1,2-Annelated quinoline derivatives, method for their preparation, intermediates, pharmaceutical composition and their use |
-
2001
- 2001-02-26 EP EP01907564A patent/EP1261348A2/en not_active Withdrawn
- 2001-02-26 JP JP2001563114A patent/JP2003525244A/en not_active Withdrawn
- 2001-02-26 WO PCT/EP2001/002168 patent/WO2001064217A2/en not_active Application Discontinuation
- 2001-02-26 CA CA002397446A patent/CA2397446A1/en not_active Abandoned
- 2001-02-26 AU AU2001235496A patent/AU2001235496A1/en not_active Abandoned
- 2001-02-26 US US10/220,220 patent/US20030078281A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1261348A2 (en) | 2002-12-04 |
WO2001064217A3 (en) | 2002-03-28 |
CA2397446A1 (en) | 2001-09-07 |
JP2003525244A (en) | 2003-08-26 |
US20030078281A1 (en) | 2003-04-24 |
WO2001064217A2 (en) | 2001-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001235496A1 (en) | Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents | |
AU2001246477A1 (en) | Farnesyl protein transferase inhibitor combinations with platinum compounds | |
AU2001240658A1 (en) | Farnesyl protein transferase inhibitor combinations with camptothecin compounds | |
PL347979A1 (en) | Farnesyl protein transferase inhibitors with in vivo | |
AU2001254672A1 (en) | Farnesyl protein transferase inhibitor combinations with an her2 antibody | |
ZA985778B (en) | Inhibitors of farnesyl protein transferase. | |
AU2001244166A1 (en) | Farnesyl protein transferase inhibitor combinations with further anti-cancer agents | |
IL143409A0 (en) | Farnesyl protein transferase inhibitors | |
AU2001252147A1 (en) | Farnesyl protein transferase inhibitor combinations | |
AU2001239275A1 (en) | Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives | |
AU2001256166A1 (en) | Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives | |
AU2001246478A1 (en) | Farnesyl protein transferase inhibitor combinations with taxane compounds | |
AU2001247882A1 (en) | Tricyclic protein kinase inhibitors | |
AU2001253197A1 (en) | Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase | |
IL163673A0 (en) | Farnesyl protein transferase inhibitors as antitumor agents | |
AU2576501A (en) | Protein kinase inhibitors | |
AU2001244167A1 (en) | Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives | |
AU8845101A (en) | Tricyclic antitumor compounds being farnesyl protein transferase inhibitors | |
AU4020897A (en) | 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors | |
AU2001242434A1 (en) | Farnesyl protein transferase inhibitor combinations with vinca alkaloids | |
HUP0202152A2 (en) | Tricyclyc farnesyl protein transferase inhibitors | |
AU2435199A (en) | Farnesyl transferase inhibitors | |
PL355887A1 (en) | Farnesyl transferase inhibitors | |
AU3514302A (en) | 0ovel farnesyl protein transferase inhibitors | |
AU2001282520A1 (en) | Grk inhibitor |